Learning to save limbs: education program aims to cut hospital stays
NCT ID NCT07201168
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested a 4-week educational program for 184 people with critical limb ischemia, a severe form of peripheral artery disease that can lead to amputation. The program included group sessions, digital materials, and peer support to teach patients about their condition and lifestyle changes. Researchers measured hospitalizations and quality of life over 12 months to see if the program made a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
structured multimodal educational program
What this could lead to
If successful, this program could offer a low-cost way to help patients manage their condition, reduce hospital visits, and improve daily life.
What could go wrong
This is a completed study with 184 participants, but education alone may not prevent serious complications like amputation. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NCJSC "Astana Medical University"
Astana, Kazakhstan